http://drugtopics.modernmedicine.com/drugtopics/Top+News/Article/list/47443 For pharmacists, from <em>Drug Topics</em>: Articles, features, and news briefs for pharmacists about drugs and drug trials, professional trends, and legal changes in the pharmacy industry 2010-07-30T04:03:38Z http://drugtopics.modernmedicine.com/drugtopics/FDA/FDA-panel-votes-to-keep-rosiglitazone-on-market-bu/ArticleStandard/Article/detail/679696?contextCategoryId=47443&ref=25 An FDA advisory panel voted 20?12 to recommend that the agency allow rosiglitazone (Avandia, GlaxoSmithKline) to remain on the market. However, most panelists want to see tougher warnings on the diabetes drug?s label, according to various media reports. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679696null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Statin-use-lowers-after-gastric-bypass-surgery/ArticleStandard/Article/detail/679706?contextCategoryId=47443&ref=25 Long-term data from a retrospective cohort study showed that hyperlipidemic obese patients had more than a 90% reduction in their need of lipid-lowering therapy following laparoscopic gastric-bypass surgery, MedPage Today reported. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679706null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Cardiology-clinicians-neglect-to-determine-patient/ArticleStandard/Article/detail/679702?contextCategoryId=47443&ref=25 The use of nutraceuticals and nonprescription over-the-counter (OTC) drugs may be high; however, the use of these agents may largely be ignored by cardiovascular clinicians, according to research published in the July 6 issue of the Annals of Internal Medicine. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679702null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/DEA-seeks-comments-on-dispensing-controlled-drugs-/ArticleStandard/Article/detail/679705?contextCategoryId=47443&ref=25 The Drug Enforcement Administration (DEA) has issued a notice in the Federal Register requesting input about the dispensing of controlled substances for residents in long-term-care (LTC) facilities. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679705null HTML http://drugtopics.modernmedicine.com/drugtopics/FDA/FDA-No-shortage-of-childrens-medications-Johnson-a/ArticleStandard/Article/detail/679701?contextCategoryId=47443&ref=25 FDA said on June 25 that it does not expect any shortage of children?s pain and allergy medications, despite Johnson &amp;amp; Johnson?s inability to resume production until at least next year, Reuters reported. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679701null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Updated-recommendations-for-endometriosis-released/ArticleStandard/Article/detail/679707?contextCategoryId=47443&ref=25 Women who suffer from endometriosis-related pain should be treated first with conservative, nonsurgical approaches and then with more invasive options if pain does not resolve, and with hysterectomy only as a last resort, according to a practice bulletin issued by the American College of Obstetricians and Gynecologists and published in the July issue of Obstetrics &amp;amp; Gynecology, reported HealthDay News. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679707null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Coumadin-1-mg-tablet-blister-packs-recalled/ArticleStandard/Article/detail/679704?contextCategoryId=47443&ref=25 A recall of 3 lots of physician sample blister packs of Coumadin 1-mg tablets and 5 lots of Coumadin 1-mg tablet hospital unit dose blister packs has been initiated by Bristol-Myers Squibb. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679704null HTML http://drugtopics.modernmedicine.com/drugtopics/Pharmacy+News/Planned-FDA-guidance-on-drug-labeling-seeks-to-hel/ArticleStandard/Article/detail/679692?contextCategoryId=47443&ref=25 FDA is once again tackling the naming, labeling, and packaging practices connected with drugs and biologics, according to a top official. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679692null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+News/NCPA-Foundation-receives-100000-for-Catalyst-Grant/ArticleStandard/Article/detail/679694?contextCategoryId=47443&ref=25 Purdue Pharma has awarded the National Community Pharmacists Association (NCPA) Foundation a $100,000 grant to advance its efforts to stimulate community-pharmacy-based research that helps improve patient care and education. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679694null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+News/Sandoz-wins-prestigious-DIANA-award-for-tacrolimus/ArticleStandard/Article/detail/679691?contextCategoryId=47443&ref=25 The Healthcare Distribution Management Association has recognized Sandoz Inc. with a 2010 Distribution Industry Award for Notable Achievements in Healthcare (DIANA) in the Best New Generic Product Introduction Award category. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679691null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/CMS-favors-continued-local-pharmacy-distribution-o/ArticleStandard/Article/detail/679708?contextCategoryId=47443&ref=25 The Centers for Medicare &amp;amp; Medicaid Services (CMS) issued a proposed regulation on June 25 that would exempt community pharmacies from the upcoming bidding process for Medicare Part B diabetes-testing supplies, along with instructions that exempt most independent community pharmacies from accreditation requirements. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679708null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Recent-low-back-pain-guidelines-offer-similar-advi/ArticleStandard/Article/detail/679742?contextCategoryId=47443&ref=25 Recent clinical practice guidelines offer similar recommendations for assessing and managing low back pain, and clinicians can improve patient care by adopting these recommendations, according to a review published in the June issue of The Spine Journal, reported HealthDay News. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679742null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Fluzone-High-Dose-vaccine-covered-under-Medicare-P/ArticleStandard/Article/detail/679710?contextCategoryId=47443&ref=25 Written confirmation is now available from the Centers for Medicare and Medicaid Services indicating that Fluzone High-Dose (Sanofi Pasteur) influenza virus vaccine for patients 65 years or older is a benefit covered by Medicare Part B and will be reimbursed for the upcoming 2010?11 influenza season. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679710null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+News/Phil-Hagerman-receives-prestigious-Ernst-amp-Young/ArticleStandard/Article/detail/679688?contextCategoryId=47443&ref=25 Phil Hagerman, RPh, president and CEO of Diplomat Specialty Pharmacy, was named Ernst &amp;amp; Young Entrepreneur of the Year for the Michigan and Northwest Ohio region. He was honored June 10 at an awards ceremony in Dearborn, Mich. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679688null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Folic-acid-vitamin-Bsub12sub-do-not-reduce-vascula/ArticleStandard/Article/detail/679700?contextCategoryId=47443&ref=25 Supplementation with folic acid and vitamin B12 over an extended period does not have a beneficial effect on vascular outcomes in individuals who have had a myocardial infarction, but it also poses no excess cancer risk, according to a study in the June 23/30 issue of the Journal of the American Medical Association, HealthDay News reported. 2010-07-20T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/302010/679700null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/North-Dakota-pharmacy-ownership-rules-under-fire-f/ArticleStandard/Article/detail/678160?contextCategoryId=47443&ref=25 A ballot initiative moving toward approval in North Dakota could open the doors to chain pharmacy in the state. 2010-07-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/282010/678160/Voters_195x210_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Vitamins-and-dietary-supplements-Why-pharmacists-r/ArticleStandard/Article/detail/678152?contextCategoryId=47443&ref=25 As Americans increasingly turn to vitamins and herbal supplements as alternatives to prescription drug use, medical professionals and government leaders worry that few realize the implications. 2010-07-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/282010/678152/JULY201010_cv1_RFC_195x210_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Study-validates-switch-to-generic-anticonvulsants/ArticleStandard/Article/detail/678166?contextCategoryId=47443&ref=25 Switching from branded to generic drugs for epilepsy did not cause increased incidents or utilization changes among patients, according to new study results. 2010-07-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/282010/678166null XML http://drugtopics.modernmedicine.com/drugtopics/Associations/NCPA-and-AADE-offer-new-diabetes-education-program/ArticleStandard/Article/detail/678158?contextCategoryId=47443&ref=25 Pharmacists now have another way to obtain continuing education credits for diabetes management. 2010-07-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/282010/678158null XML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/MTM-bill-seeks-to-help-seniors-manage-medications-/ArticleStandard/Article/detail/676930?contextCategoryId=47443&ref=25 Sens. Kay R. Hagan (D-N.C.) and Al Franken (D-Minn.) have introduced The Medication Therapy Management (MTM) Expanded Benefits Act, a bill that will allow seniors with one chronic illness to thoroughly review all their medications with a pharmacist in a one-on-one session. 2010-07-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676930null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-announces-ongoing-cardiovascular-safety-review/ArticleStandard/Article/detail/676741?contextCategoryId=47443&ref=25 FDA has announced that the agency is currently evaluating whether the use of the angiotensin II receptor blocker (ARB) olmesartan (Benicar, Daiichi Sankyo; also sold in combination with hydrocholorothiazide as Benicar HCT) was associated with increased cardiovascular mortality. 2010-07-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676741null HTML http://drugtopics.modernmedicine.com/drugtopics/Community+Practice/FDA-launches-educational-videos-for-pharmacists/ArticleStandard/Article/detail/678164?contextCategoryId=47443&ref=25 In the first of its &#34;FDA Drug Info Rounds,&#34; a new series of educational videos for pharmacists, FDA is tackling unapproved dispensing of colchicine. 2010-07-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/282010/678164null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Use-of-e-prescription-soars/ArticleStandard/Article/detail/678153?contextCategoryId=47443&ref=25 The number of e-prescriptions filled last year soared 181% to 191 million, according to &#34;Advancing Healthcare in America,&#34; a report issued by Surescripts in Alexandria, Va. 2010-07-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/282010/678153null XML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Diabetes-prevention-Meta-analysis-finds-glitazones/ArticleStandard/Article/detail/676954?contextCategoryId=47443&ref=25 A systematic review assessing the comparative effectiveness of oral anti-diabetic drugs for preventing patients at high risk from progressing to type 2 diabetes has found glitazones (pioglitazone, rosiglitazone), biguanides (metformin), and alpha-glucosidase inhibitors (AGIs; acarbose, voglibose) reduced the relative risk of diabetes by as much as 63%, whereas insulin secretagogues (sulfonylureas and glinides) had no effect. 2010-07-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676954null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Findings-add-fuel-to-the-rosiglitazone-co/ArticleStandard/Article/detail/677220?contextCategoryId=47443&ref=25 A new post-hoc study of rosiglitazone and cardiac events in patients with type 2 diabetes is adding to the controversy surrounding the thiazolidinedione (TZD) agent. Lead author Richard Bach, MD, associate professor of medicine, Washington University, St. Louis, Mo., presented the new data during a late-breaking clinical study symposium Tuesday morning at the 70th Scientific Sessions of the American Diabetes Association, taking place in Orlando, Fla. 2010-07-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/677220null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Glycemic-control-better-with-a-sensor-aug/ArticleStandard/Article/detail/677100?contextCategoryId=47443&ref=25 Use of a sensor-augmented pump is superior to multiple daily insulin injections in reducing glycated hemoglobin levels without an increased risk of hypoglycemia in both adults and children with type 1 diabetes who are not in good control on multiple daily injections, said Richard M Bergenstal, MD. 2010-07-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/677100null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Diabetic-retinopathy-reduced-by-intensive/ArticleStandard/Article/detail/677224?contextCategoryId=47443&ref=25 Five-year data from a seminal study in patients with type 2 diabetes who are at especially high risk of heart disease show that intensive glucose control does slow the progression of microvascular disease, but mortality is increased and there is no benefit on macrovascular complications. 2010-07-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/677224null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-The-latest-in-nonnutritive-sweeteners/ArticleStandard/Article/detail/677143?contextCategoryId=47443&ref=25 Patients and providers who look for saccharine packets may like the product&amp;mdash;or they may not realize the range of nonnutritive, noncaloric sweeteners currently available. 2010-07-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/677143null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Blood-pressure-target-for-high-risk-type-/ArticleStandard/Article/detail/677253?contextCategoryId=47443&ref=25 At 5 years? follow-up, intensive blood-pressure reduction to a target systolic blood pressure (SBP) less than 120 mm Hg did not reduce the risk of a composite cardiovascular outcome, compared with a target SBP of less than 140 mm Hg in patients with type 2 diabetes at high risk of cardiovascular events, although it did reduce the incidence of stroke, said William Cushman, MD, who presented the results from the blood pressure portion of the ACCORD (Action to Control Cardiovascular Risk in Diabetes) study to a gathering at the 70th Scientific Sessions of the American Diabetes Association in Orlando, Fla. 2010-07-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/677253null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Community-based-lifestyle-program-helps-o/ArticleStandard/Article/detail/677102?contextCategoryId=47443&ref=25 A community-based behavioral lifestyle intervention results in significant reductions in glycated hemoglobin, fasting blood glucose, and body weight in overweight/obese individuals with prediabetes, said David Goff Jr, MD, PHD. 2010-07-01T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/677102null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Herbals-helpful-for-diabetes-care-but-the/ArticleStandard/Article/detail/676999?contextCategoryId=47443&ref=25 Herbals and supplements such as silymarin (milk thistle), fish oil, and red rice yeast can improve some of the conditions associated with diabetes, but the evidence is slim. 2010-06-30T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676999null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Hypoglycemic-episodes-linked-to-oral-anti/ArticleStandard/Article/detail/676949?contextCategoryId=47443&ref=25 Hypoglycemic episodes in type 2 diabetes predict discontinuation of oral antidiabetic drugs as well as higher costs of care. 2010-06-30T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676949null HTML http://drugtopics.modernmedicine.com/drugtopics/Top+News/ADA-2010-Gut-bacteria-can-affect-obesity/ArticleStandard/Article/detail/676995?contextCategoryId=47443&ref=25 Obesity and leanness are more than calories in and energy out. The amount of adipose tissue an individual carries is also a function of his or her intestinal microbiota. Research in mice and humans suggests that individuals with more Firmicutes and fewer Bacteroidetes tend to be more obese. 2010-06-30T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676995null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Will-DPP-4-inhibitors-replace-sulfonylure/ArticleStandard/Article/detail/676941?contextCategoryId=47443&ref=25 Although their ability to control glycemia is essentially the same, do other merits of dipeptidyl peptidase 4 (DPP-4) inhibitors favor their replacing sulfonylureas in the treatment armamentarium for type 2 diabetes? Michael Nauck, MD, and David Matthews, FRCP, were on opposing sides of this issue. 2010-06-30T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676941null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Among-older-diabetics-improvements-in-HbAsub1csub-/ArticleStandard/Article/detail/676996?contextCategoryId=47443&ref=25 A telemedicine intervention in older adults with diabetes improved hemoglobin (Hb) A1c levels, and this improvement in HbA1c was associated with more frequent uploading of glucose values, found Ruth Weinstock, MD, PhD, addressing a gathering at the 70th Scientific Sessions of the American Diabetes Association meeting in Orlando, Florida. 2010-06-30T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676996null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Cardiac-disease-in-diabetes-still-a-black/ArticleStandard/Article/detail/676997?contextCategoryId=47443&ref=25 In 1992, researcher Edwin Bierman, MD, described the development of cardiovascular disease in diabetes as a black box. Nearly 20 years later, it is still a black box. 2010-06-30T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676997null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Metformin-associated-with-lower-risk-of-m/ArticleStandard/Article/detail/676948?contextCategoryId=47443&ref=25 In patients with diabetes and concomitant heart failure who are naive to oral antidiabetic drugs, the introduction of metformin use is associated with a lower risk of mortality than the introduction of other oral antidiabetic drugs, found Dean T Eurich, PhD. 2010-06-30T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676948null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-One-year-data-on-exenatide-show-that-impr/ArticleStandard/Article/detail/676732?contextCategoryId=47443&ref=25 In patients with type 2 diabetes, treatment with exenatide once weekly for 1 year results in sustained improvements in glycemic control, body weight, cardiovascular risk markers, and markers of hepatic injury, according to a pooled analysis of 2 large clinical trials. 2010-06-29T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676732null HTML http://drugtopics.modernmedicine.com/drugtopics/Top+News/ADA-2010-Glycated-hemoglobin-levels-correlate-stro/ArticleStandard/Article/detail/676728?contextCategoryId=47443&ref=25 An ancillary study to the ARIC (Atherosclerosis Risk in Communities) study supports the most recent (2010) ADA risk categories of glycated hemoglobin in identifying future risk of developing diabetes and macrovascular and microvascular disease. 2010-06-29T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676728null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Liraglutide-clinical-trial-program-sugges/ArticleStandard/Article/detail/676737?contextCategoryId=47443&ref=25 A post hoc analysis of 5 clinical trials of liraglutide suggests that it was significantly better than active comparators on a composite end point of glycated hemoglobin less than 7% without hypoglycemia or weight gain, reported French investigators. 2010-06-29T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676737null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Cell-phone-reporting-coaching-can-improve/ArticleStandard/Article/detail/676740?contextCategoryId=47443&ref=25 Clinical reporting and coaching systems can significantly reduce glycated hemoglobin levels without increasing the costs of care. 2010-06-29T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676740null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Bolster-self-determination-to-boost-exerc/ArticleStandard/Article/detail/676739?contextCategoryId=47443&ref=25 Exercise research has found that boosting patients' self-determination is an effective way to improve their motivation to exercise. 2010-06-29T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676739null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Diet-can-affect-type-2-diabetes-risk/ArticleStandard/Article/detail/676730?contextCategoryId=47443&ref=25 Dietary choices can have a discernable effect on the risk of developing type 2 diabetes. That conclusion is based on analysis of men in the Health Professionals Follow-Up Study (HPFS), which followed 41,212 men for up to 20 years. 2010-06-29T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676730null HTML http://drugtopics.modernmedicine.com/drugtopics/Treatment+Areas%3A+Diabetes/ADA-2010-Blame-calories-not-fructose/ArticleStandard/Article/detail/676735?contextCategoryId=47443&ref=25 Fructose is the sugar consumers love to hate. It gets the blame for obesity, metabolic syndrome, and a variety of dietary ills. But according to at least one expert, the fructose content in high-fructose corn syrup just isn't that high. 2010-06-29T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676735null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-TZDs-associated-with-increased-hip-fractu/ArticleStandard/Article/detail/676434?contextCategoryId=47443&ref=25 New data from Scotland suggest that drug regulators should change labeling on thiazolidinediones to warn of elevated risk for hip fractures in both men and women. 2010-06-28T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676434null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Near-agreement-on-CV-risk-assessment-for-/ArticleStandard/Article/detail/676432?contextCategoryId=47443&ref=25 It was billed as a debate, but played as a mild disagreement. Should new diabetes drugs submitted to the FDA have a higher bar for cardiovascular safety than other drugs? 2010-06-28T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676432null HTML http://drugtopics.modernmedicine.com/drugtopics/Top+News/ADA-2010-Liraglutide-more-successful-than-sitaglip/ArticleStandard/Article/detail/676389?contextCategoryId=47443&ref=25 Liraglutide is more successful in reducing glycated hemoglobin levels to 7% or less regardless of baseline glycated hemoglobin level compared with sitagliptin in adults with type 2 diabetes, said Melanie Davies, MD, MB ChB, professor of diabetes medicine, University of Leicester, United Kingdom. 2010-06-28T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676389null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Obesity-poor-glycemic-control-predict-whi/ArticleStandard/Article/detail/676447?contextCategoryId=47443&ref=25 In clinical practice, exenatide is often started in patients with type 2 diabetes who are on insulin therapy, even though the prescribing information states that the concurrent use of exenatide with insulin has not been studied and cannot be recommended, according to analysis of a large nationwide database. 2010-06-28T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676447null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Diabetes-an-independent-risk-factor-for-v/ArticleStandard/Article/detail/676429?contextCategoryId=47443&ref=25 New data suggest that although diabetes doubles the risk of vascular disease, elevated fasting glucose has little effect on the risk of coronary heart disease or major ischemic events. 2010-06-28T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676429null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Exenatide-beats-insulin-glargine-in-glyca/ArticleStandard/Article/detail/676393?contextCategoryId=47443&ref=25 Patients who are not well controlled on metformin may get better control of glycated hemoglobin levels and weight using once-weekly exenatide than by titrating insulin glargine. 2010-06-28T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676393null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-2010-Is-HDL-too-much-of-a-good-thing-in-type-1/ArticleStandard/Article/detail/676397?contextCategoryId=47443&ref=25 Too much high-density lipoprotein (HDL) cholesterol could be harmful for women with type 1 diabetes. Men with type 1 diabetes, however, continue to experience cardioprotection with increasing HDL, said Tina Costacou, PhD. 2010-06-28T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/272010/676397null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-debuts-new-educational-video-series-on-drug-sa/ArticleStandard/Article/detail/675593?contextCategoryId=47443&ref=25 FDA last month launched &#34;FDA Drug Info Rounds,&#34; a new educational video series for pharmacists. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675593null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-OKs-2009-H1N1-influenza-test-for-use-beyond-em/ArticleStandard/Article/detail/675479?contextCategoryId=47443&ref=25 FDA has cleared Simplexa Influenza A H1N1 (2009), a test for the 2009 H1N1 influenza virus in patients with signs and symptoms of respiratory infection. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675479null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Community-pharmacists-to-gather-for-annual-NCPA-co/ArticleStandard/Article/detail/675611?contextCategoryId=47443&ref=25 The National Community Pharmacists Association (NCPA) will present the latest in pharmacy education, case studies, and real-world, business-oriented information for the independent community-pharmacy industry at its 112th Annual Convention and Trade Exposition taking place at the Pennsylvania Convention Center in Philadelphia Oct. 23 to 27. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675611null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Metformin-linked-to-vitamin-deficiency/ArticleStandard/Article/detail/675622?contextCategoryId=47443&ref=25 Patients treated over long periods with the diabetes drug metformin (Glucophage, Bristol-Myers Squibb) are at risk of developing vitamin-B12 deficiency, according to a study published in the British Medical Journal, Reuters has reported. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675622null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Childrens-consumption-of-chronic-medications-on-th/ArticleStandard/Article/detail/675456?contextCategoryId=47443&ref=25 In 2009, the drug trend for children, a measure of prescription-spending growth, increased 10.8%, driven by a 5% increase in drug utilization and higher medication costs, according to the Medco &#34;2010 Drug Trend Report.&#34; 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675456null HTML http://drugtopics.modernmedicine.com/drugtopics/Pharmacy+News/FDA-teams-with-Drugscom-to-expand-access-to-health/ArticleStandard/Article/detail/675592?contextCategoryId=47443&ref=25 FDA will provide access to its health information for consumers through a collaboration with Drugs.com, which will post the information at its website and on its mobile phone platform. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675592null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Counterfeit-Tamiflu-sold-on-Internet-puts-consumer/ArticleStandard/Article/detail/675595?contextCategoryId=47443&ref=25 FDA notified consumers and healthcare professionals that a product represented as &#34;Generic Tamiflu&#34; being sold on the Internet does not contain Tamiflu's active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675595null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/CVS-Caremark-Generation-Health-outline-target-medi/ArticleStandard/Article/detail/675487?contextCategoryId=47443&ref=25 CVS Caremark and Generation Health announced 13 drug therapies that will be included in the initial offering of their integrated Genetic Benefit Management service. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675487null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+News/Consumers-find-pharmacists-most-trustworthy/ArticleStandard/Article/detail/675619?contextCategoryId=47443&ref=25 Pharmacists are the most trusted source for medical research information, according to a recent survey. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675619null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-to-post-risk-summaries-of-approved-drugs-on-ne/ArticleStandard/Article/detail/675591?contextCategoryId=47443&ref=25 FDA announced that it will release risk summaries about medicines approved after September 2007 and post them quarterly to a publicly accessible website, Reuters reported. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675591null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-probes-hundreds-of-complaints-about-Johnson-am/ArticleStandard/Article/detail/675620?contextCategoryId=47443&ref=25 FDA is investigating hundreds of consumer complaints involving children's medicines recalled by Johnson &amp;amp; Johnson on April 30, according to a congressional memo, the Associated Press reported. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675620null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+News/AMA-opens-dialogue-with-pharmacy-organizations/ArticleStandard/Article/detail/675616?contextCategoryId=47443&ref=25 The American Medical Association (AMA) has responded favorably to concerns expressed in April by the American Pharmacists Association and six other pharmacy associations. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675616null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-sends-letters-to-Illumina-and-genomics-suspect/ArticleStandard/Article/detail/675491?contextCategoryId=47443&ref=25 FDA has informed four consumer genomics services providers and Illumina that it believes the firms are selling unapproved diagnostic devices, according to a report published by the GenomeWeb Daily News. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675491null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+News/Walgreens-and-CVS-reach-agreement/ArticleStandard/Article/detail/675617?contextCategoryId=47443&ref=25 Walgreens and CVS Caremark have signed a multi-year contract to keep Walgreens in the Caremark pharmacy network, resolving recent issues between the drugstore chains, according to The Wall Street Journal. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675617null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Overuse-of-antibiotics-spurs-vicious-cycle/ArticleStandard/Article/detail/675613?contextCategoryId=47443&ref=25 Patients whose doctors over-prescribe antibiotics may develop drug resistance that can last up to a year, putting them and others at risk when more serious treatment is needed, according to a study published in May in the British Medical Journal. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675613null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/International-Public-Health-amp-Pharmacy-Issues-Co/ArticleStandard/Article/detail/675614?contextCategoryId=47443&ref=25 Pharmacists Planning Service, Inc. is calling for papers for its 17th International Public Health &amp;amp; Pharmacy Issues Conference aboard Royal Caribbean's Adventure of the Seas. 2010-06-23T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/262010/675614null HTML http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/2009-Top-200-branded-drugs-by-retail-dollars/ArticleStandard/Article/detail/674961?contextCategoryId=47443&ref=25 Which drugs were most popular in 2009? Check out Drug Topics' list of the Top 200 branded drugs in 2009, ranked by retail dollars. 2010-06-17T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/252010/674961null PDF http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/2009-Top-200-branded-drugs-by-total-prescriptions/ArticleStandard/Article/detail/674969?contextCategoryId=47443&ref=25 Which drugs were most popular in 2009? Check out Drug Topics' list of the Top 200 branded drugs in 2009, ranked by total prescriptions. 2010-06-17T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/252010/674969null PDF http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/2009-Top-200-generic-drugs-by-total-prescriptions/ArticleStandard/Article/detail/674982?contextCategoryId=47443&ref=25 Which drugs were most popular in 2009? Check out Drug Topics' list of the Top 200 generic drugs in 2009, ranked by total prescriptions. 2010-06-17T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/252010/674982null PDF http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/2009-Top-200-generic-drugs-by-retail-dollars/ArticleStandard/Article/detail/674976?contextCategoryId=47443&ref=25 Which drugs were most popular in 2009? Check out Drug Topics' lists of the Top 200 generic drugs in 2009, ranked by retail dollars. 2010-06-17T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/252010/674976null PDF http://drugtopics.modernmedicine.com/drugtopics/Top+News/Safe-disposal-of-pharmaceuticals-a-growing-concern/ArticleStandard/Article/detail/672260?contextCategoryId=47443&ref=25 A growing public health concern is the presence of potentially harmful pharmaceuticals in drinking water, due to improper disposal of waste prescription drugs. At least 20 states now have collection programs for unused medications. The greater use of such programs requires the reeducation of the community to raise awareness of the dangers and of the solutions to the problem of waste pharmaceuticals. The more convenient the options for disposal of most medications, the more likely they will be disposed of properly. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/232010/672260null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/CVS-faces-probes-by-FTC-HHS-DEA-CEO-Ryan-to-retire/ArticleStandard/Article/detail/671831?contextCategoryId=47443&ref=25 Both the FTC?s consumer protection and competition bureaus are spearheading an investigation into CVS Caremark?s alleged monopolistic practices. HHS is investigating possible false Medicare claims. DEA is investigating charges of improper sale of pseudoephedrine in 2007 and 2008. And the SEC has received complaints of insider trading. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/222010/671831null HTML http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/OTC-genetic-tests-Coming-soon-to-a-pharmacy-near-y/ArticleStandard/Article/detail/671834?contextCategoryId=47443&ref=25 On May 11th the news that Walgreens, partnering with Pathway Genomics, was going to offer customers a genetic testing kit made headlines almost as fast as a world peace announcement. Then Pathway received a letter of inquiry from the FDA, and Walgreens decided to halt the initiative until more clarity was reached. However, when genetic testing kits do become available at retail outlets, there will be a need for plenty of patient education, which pharmacists can best provide. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/222010/671834null HTML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Personalized-medicine-and-the-future-of-pharmacy/ArticleStandard/Article/detail/673894?contextCategoryId=47443&ref=25 The promise of personalized medicine is approaching realization. As more medications are developed, pharmacists will be on the front line of individualized prescribing based upon genome-based diagnostic tests. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/242010/673894/June2010cvr-195X210_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Ohio-honors-pharmacy-history-with-medicinal-garden/ArticleStandard/Article/detail/673889?contextCategoryId=47443&ref=25 Named for Ohio pharmacy pioneer John Uri Lloyd, the Lloyd Medicinal Garden at the governor's residence in Columbus pays tribute to the history of the profession. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/242010/673889null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Marin-County-swaps-mercury-thermometers-for-digita/ArticleStandard/Article/detail/673898?contextCategoryId=47443&ref=25 As part of Earth Week 2010, California pharmacies and the Marin Sanitary District collaborated to reduce household amounts of mercury, a toxic substance associated with damage to the nervous system, kidneys, liver, lungs, and immune system. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/242010/673898null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Aggressive-lipid-control-fails-to-benefit-type-2-d/ArticleStandard/Article/detail/673892?contextCategoryId=47443&ref=25 Adding fenofibrate to statin therapy fails to reduce cardiovascular events in patients with type 2 diabetes, according to results of the first trial to evaluate combination therapy presented at the 59th annual scientific session of the American College of Cardiology. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/242010/673892/June2010_bp_hba1c_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Pharmacy-response-to-the-AMA-Scope-of-Practice-Dat/ArticleStandard/Article/detail/673895?contextCategoryId=47443&ref=25 The CEO of APhA responds to the recent AMA policy statement on the place of pharmacists in healthcare. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/242010/673895null XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Pharmacists-to-give-a-helping-hand-to-the-newly-in/ArticleStandard/Article/detail/673890?contextCategoryId=47443&ref=25 The healthcare reform legislation signed into law March 23 is expected to give healthcare access to 32 million Americans who are currently uninsured. The legislation gives pharmacists a role in helping alleviate the influx of new patients. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/242010/673890/June2010_hc_reform_mtm_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/NACDS-honors-pharmacy-industry-leaders/ArticleStandard/Article/detail/673891?contextCategoryId=47443&ref=25 The National Association of Chain Drug Stores recognized Charles Vance Burnett, JD, BS Pharm, and Stanley F. Barshay with its highest honors at the 2010 annual meeting in Palm Beach, Fla. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/242010/673891null XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Methamphetamine-Prescription-only-or-e-tracking-sy/ArticleStandard/Article/detail/673896?contextCategoryId=47443&ref=25 Oregon's law requiring prescriptions for pseudoephedrine products practically eliminated its illicit methamphetamine problem. But some pharmacists, consumer groups, and the drug industry say that it will increase healthcare costs and inconvenience consumers. They think electronic sales-tracking systems would be a better approach. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/242010/673896/June2010_methlabs_smurfers_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/NCPA-partners-with-Sharps-for-safe-disposal-of-unu/ArticleStandard/Article/detail/673885?contextCategoryId=47443&ref=25 More than 850 U.S. community pharmacies are participating in the &#34;Dispose My Meds&#34; campaign sponsored by the National Community Pharmacists Association and Sharps Compliance. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/242010/673885null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pharmacy-CQI-What-to-bear-in-mind-when-you-fill-ou/ArticleStandard/Article/detail/673887?contextCategoryId=47443&ref=25 Pharmacies can enhance their continuous quality improvement program results by working on three critical elements: implementation, training, and monitoring. 2010-06-15T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/242010/673887null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Rash-of-drug-thefts-triggers-enhanced-industry-vig/ArticleStandard/Article/detail/668521?contextCategoryId=47443&ref=25 In response to a flurry of drug thefts plaguing pharmaceutical manufacturers and distributors in recent months, the Center for Healthcare Supply Chain Research, an arm of the Healthcare Distribution Management Association (HDMA), is holding a seminar on Supply Chain Security May 10 and 11 in Alexandria, Va. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668521null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Two-chains-launch-health-sites/ArticleStandard/Article/detail/668530?contextCategoryId=47443&ref=25 Supermarket chains Albertsons and Harris Teeter have launched online tools to help shoppers pursue health and wellness. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668530null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Healthcare-reform-and-pharmacies/ArticleStandard/Article/detail/668536?contextCategoryId=47443&ref=25 An overview of several provisions of &#34;The Patient Protection and Affordable Care Act&#34; affecting pharmacies and pharmacy practice. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668536null XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Bruce-Roberts-leaves-NCPA-for-a-PBM-with-a-differe/ArticleStandard/Article/detail/668539?contextCategoryId=47443&ref=25 Even though Bruce Roberts strongly criticized pharmacy benefit managers (PBMs) during his tenure as executive vice president and CEO of the National Community Pharmacists Association (NCPA), he is enthusiastic about the prospect of heading up a type of PBM. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668539null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Avandia-safety-under-fire-again/ArticleStandard/Article/detail/668533?contextCategoryId=47443&ref=25 A report issued by the Senate Finance Committee earlier this year noted that Avandia is associated with 83,000 excess heart attacks occurring between 1999 and 2007. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668533null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Kerr-Drug-2010-Chain-of-the-Year/ArticleStandard/Article/detail/668535?contextCategoryId=47443&ref=25 Drug Topics' 2010 Chain of the Year award goes to Kerr Drug, a regional chain based in Raleigh, N.C. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668535/drtp0510_cv1_RFC[1]_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Compounded-drugs-give-indies-an-edge/ArticleStandard/Article/detail/668532?contextCategoryId=47443&ref=25 Compounded medicines &amp;mdash; also called personalized solutions &amp;mdash; have become an important element in many independent pharmacies. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668532/drtp_0510_barnett_RFC_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-approves-brand-name-change-for-dexlansoprazole/ArticleStandard/Article/detail/668537?contextCategoryId=47443&ref=25 FDA would like to alert healthcare providers to the recent proprietary name change for dexlansoprazole delayed-release capsules. Now known as Dexilant, dexlansoprazole is the proton pump inhibitor formerly known as Kapidex. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668537/drtp0510_dexilant_RFC_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pharmacy-benefit-managers-need-to-be-reined-in/ArticleStandard/Article/detail/668531?contextCategoryId=47443&ref=25 Prescription-drug benefit plans prosper by exploiting a non-transparent, non-accountable system. This needs to change. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668531null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/US-pharmacists-aid-stricken-Haitians/ArticleStandard/Article/detail/668527?contextCategoryId=47443&ref=25 While many people were trying to escape the scenes of death and destruction within Haiti, pharmacists Tamara Neff and Jess Streif were finalizing plans to travel there. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668527/drtp0510_tentcity_RFC_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Koda-Kimble-wins-Remington/ArticleStandard/Article/detail/668534?contextCategoryId=47443&ref=25 Clinical pharmacy pioneer Mary Anne Koda-Kimble, PharmD, dean of the School of Pharmacy at University of California, San Francisco, was awarded the 2010 Remington Honor Medal, the highest honor given by the American Pharmacists Association, at its recent annual meeting in Washington. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668534null XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Is-it-time-for-pharmacists-to-unionize/ArticleStandard/Article/detail/668529?contextCategoryId=47443&ref=25 There is an answer to 12-hour shifts, inadequate support, 20-minute lunch hours, and no bathroom breaks. Ask the United Steelworkers of America. 2010-05-05T04:00:00Z XML http://drugtopics.modernmedicine.com/drugtopics/Associations/Pharmacists-termed-innovators-and-leaders-at-APhA-/ArticleStandard/Article/detail/668538?contextCategoryId=47443&ref=25 The American Pharmacists Association annual meeting opened in Washington just days before the big March vote on healthcare reform, and a number of people from the political realm were there to praise pharmacists and ask for their support. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668538null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/New-black-box-warning-for-clopidogrel/ArticleStandard/Article/detail/668524?contextCategoryId=47443&ref=25 FDA announced that clopidogrel, an antiplatelet agent given to reduce the risk of heart attack, unstable angina, stroke, and cardiovascular death in patients with cardiovascular disease, will require a new black-box warning about its reduced effectiveness in patients who are poor metabolizers of the drug. 2010-05-05T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192010/668524null XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pharmacist-intervention-boosts-patient-compliance/ArticleStandard/Article/detail/664504?contextCategoryId=47443&ref=25 While approximately 40% of patients with schizophrenia have been partly or entirely nonadherent with antipsychotic medications, patient adherence improved dramatically when Veterans Affairs pharmacy staff coordinated these patients' medications, according to a new study. 2010-04-07T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/152010/664504/blisterpack_pg27_april_2010_flash.jpg XML http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Stressed-out-pharmacists-have-a-choice/ArticleStandard/Article/detail/664505?contextCategoryId=47443&ref=25 If you don't like the &#34;reality&#34; you're looking at, you can change the person who's doing the looking. 2010-04-07T04:00:00Z http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/152010/664505null XML